AllDocs -> cancers

prostate cancer Developing a Prostate Cancer Screening Decision Aid for African- American Men Alton Hart, Jr., MD,MPH University of Washington Fred Hutchinson Cancer Research Center 3/8/04 Project Goal To prepare African-American men for shared decision-making in prostate cancer screening by developing a highly interactive and innovative electronic decision-making tool. Specific Aims To identify behavioral factors from the Preventive Health Model that might influence prostate cancer screening behavior in African-American men using qualitative methods To identify the most salient factors of the Preventive Health Model in predicting prostate cancer screening behavior by estimating the prevalence of key predictors of prostate cancer screening. To explore reactions of African-American men aged 40-70 years to an interactive ...

FOR IMMEDIATE RELEASE Contact: Amanda Widtfeldt April 6, 2004 312.926.2955 awidtfel@nmh.org Familial Prostate Cancer Screening Program Opens at Northwestern Memorial Hospital Researchers enrolling people with a family history of prostate cancer in research study that aims to map the genetics of prostate cancer CHICAGO – A Familial Prostate Cancer Screening Program is opening at Northwestern Memorial Hospital in Chicago to help researchers zero in on genes that may lead them to new screening tests and eventually new strategies to prevent and treat one of the top two cancer killers in men. “We believe prostate cancer is the most hereditary of all cancers. If we can find out which genes are involved in the development of prostate cancer and then figure out what goes wrong when they are mutated, we ...

prostate cancer Hot Topics in Prostate Cancer – An Update Joseph Bilik MD FACS Florida Urology Specialists ALTERNATIVE AND COMPLEMENTARY MEDICINE Lifestyle Changes and Prostate Cancer Fat and Prostate cancer and Heart Disease Saturated (Hydrogenated) Fats Trans-Fatty Acids (partially hydrogenated fat) Fruits and Vegetables (tomatoes, tomato products, lycopenes) Soy products/Flaxseed and other plant estrogens Obesity Physical Activity and Exercise Dietary Supplements Chemopreventative Agents and Prostate Cancer Selenium Vitamin E PC-SPES TRIALS - PCPT, Selenium, and Vitamin E Chemoprevention Trial-Select NSAIDS – ASA, nonselective NSAIDS, Selective Cox-2 Inhibitors Saw Palmetto DHEA Lifestyle Changes – Dietary Supplements for Special Conditions ...

PROSTATE CANCER C H A P T E R 1 1 Page 2 C o m m i t t e e M e m b e r s Donna Cox, MEd (Co-chairperson) - The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, State Council on Cancer Control Katherine Farrell, MD, MPH (Co-chairperson) - Anne Arundel County Department of Health, State Council on Cancer Control Dale Berry - Park Heights Community Health Alliance Marsha Bienia, MBA - Center for Cancer Surveillance and Control, Maryland Department of Health & Mental Hygiene Judge Ralph Burnett - Garrett County District Court, Board Member of the National Prostate Cancer Coalition Subha Chandar, MPH - Washington Adventist Hospital Gwendolyn Crawford - Garden of Prayer Cancer Prevention and Education Center Nancy Dawson, MD - University of Maryland Greenebaum Cancer Center Gretchen Derewicz ...

— T HIRD E DITION — S E P T E M B E R 2 0 0 2 Published as a public service by Prostate Cancer Fund (A special program of Project Cure) P.O. Box 96673, Washington, D.C. 20090-6673 • 1-800-716-2152 Treatment of Prostate Cancer with Natural Therapeutics MT952-REP Page 2 2 Introduction: The prostate is a gland in the male reproductive system that helps produce semen, the thick fluid that carries sperm cells. The prostate is a walnut-sized structure located beneath the bladder of males. It surrounds the upper part of the urethra. The urethra is the tube that carries urine from the bladder. Prostate function is regulated by testosterone, the male sex hormone produced primarily in the testicles. Prostate cancer represents a significant number ...

Cryotherapy Simulator for Localized Prostate Cancer James K. Hahn, Ph.D. 1 , Michael J. Manyak, M.D. 2 , Ge Jin 1 , Dongho Kim 1 , John Rewcastle, Ph.D. 3 , Sunil Kim, Ph.D. 4 , and Raymond J. Walsh, Ph.D. 2 1 Institute for Computer Graphics 2 Department of Urology , School of Medicine and Health Sciences The George Washington University 3 Department of Radiology, University of Calgary and Endocare Inc. 4 Department of Biomedical Engineering, Hanyang University Abstract . Cryotherapy is a treatment modality that uses a technique to selectively freeze tissue and thereby cause controlled tissue destruction. The procedure involves placement of multiple small diameter probes through the perineum into the prostate ...

Action Plan on Prostate Cancer for the State of Texas Developed by: Texas Medical Association’s Physician Oncology Education Program Andrew Miller, MHSE, CHES Project Director Robin C. Calloway Project Coordinator Debbie Celusniak Graphic Artist This project is a collaboration of these agencies and organizations: American Cancer Society, Texas Division, Inc. Texas Cancer Council Texas Department of Health Texas Medical Association Funded by the Centers for Disease Control and Prevention, under grant number U55-CCU616039 This report is also available on the Web at: www.tcc.state.tx.us FEBRUARY 2002 TEXAS CANCER COUNCIL Page 2 Page 3 CONTENTS I iii Contents Introduction v ...

THALOMID ® (thalidomide) ENL Multiple Myeloma Renal Cell Cancer Prostate Cancer Inflammatory/Immunological Ritalin ® Program Focalin ™ : ADD/ADHD Focalin: Cancer Fatigue Ritalin LA: ADD/ADHD Focalin LA: ADD/ADHD ALKERAN ® : Multiple Myeloma/Ovarian Cellular Therapeutics Stem Cell Transplants*: Cancer Ambio-dry ™ *: Opthalmology IMiDs TM REVLIMID ™ : Multiple Myeloma (FDA Fast Track) REVLIMID: Metastatic Melanoma REVLIMID: MM (FDA Fast Track) REVLIMID: MDS (FDA Fast Track) REVLIMID: MDS 5Q- (FDA Fast Track) REVLIMID: Solid Tumors REVLIMID: Inflammatory/Immunological ACTIMID ™ : Multiple Myeloma ACTIMID: Prostate ...

10468 10463 10453 10457 10471 10458 10451 10452 10460 10472 10456 10455 10454 10459 10474 10466 10464 10465 10469 10461 10462 10475 10473 10467 10470 Comparison of individual zip codes with expected incidence more than 100% above expected 50% to 100% above expected 15% to 49% above expected within 15% of expected 15% to 50% below expected more than 50% below expected very sparse data Prostate Cancer Incidence by ZIP Code Adjusted for Age and Race Bronx County 1994-1998

It is important to distinguish between prostate cancer and other prostate problems. Different prostate problems can cause similar symptoms, but they are treated differently. This is why an accurate diagnosis is important. In order to work out which problem you may have you will need to undergo some tests. When the results from all these tests are examined, you and your doctors should know more about what, if anything, is wrong. Sometimes, some of the more complex tests may not be performed, because the diagnosis is clear without them. The basic tests that your GP can do are: • PSA ( Prostate Specific Antigen) test • DRE (Digital Rectal Examination) Hospital tests you may have are: • TRUS (Trans-Rectal Ultra Sound) biopsy • CT scan • MRI scan • Bone Scan Basic Tests: ...

The Prostate Cancer Charity provides support and information to anyone concerned about prostate cancer . We also fund research into the causes of, and treatments for, prostate cancer . In addition to these three aims, we work to raise the profile of prostate cancer . Support Our confidential Helpline, staffed by trained nurses, is open from 10 am to 4 pm Monday to Friday. The nurses answer questions from anyone concerned about prostate cancer . You may be a man who has it, or be worried that you have it. You may have a close family member who is affected, or be a person who wants to know more. Anyone with a concern can ring us. We will do our best to answer your questions - or find out more if we don’t know the answer immediately. Calls may be monitored for training and quality purposes. The Helpline number is 0845 300 8383 ...

At different times during your treatment for prostate cancer , you will have different dietary needs. These will also depend on your course of treatment. For example, you may be about to have an operation or recovering after one, or just about to start a course of chemotherapy or radiotherapy. Whatever your situation, it is important that you follow a well balanced diet. This will help to maintain your strength. A well balanced diet comes from eating foods from the main food groups, and eating as great a variety of foods as possible. Foods can be divided up into: • Protein • Fats • Carbohydrates • Vitamins and minerals. Proteins are needed for tissue growth, wound healing and muscle strength. Good sources are found in meat, fish, poultry, cheese, eggs, milk, yogurt and pulses such as beans or lentils. Fats and carbohydrates ...

13.1. INTRODUCTION AND SUMMARY Prostate cancer was the second commonest non-cutaneous cancer in men (Table 13.1). Men had a 5% risk of developing prostate cancer before age 75, and a 1.6% chance of dying before the same age. Prostate cancer incidence has increased since 1994, at an annual rate of 1.6%. Whether this is due to better case- finding, more incidental diagnoses or a true increase in incidence is unknown. Table 13.1. Summary of incidence and mortality statistics: prostate cancer INCIDENT CASES DEATHS All cancers (invasive, in situ and uncertain) (ICD-O-2 C61) 1997 cases 1133 536 % of all cancers (male) 10.7% 13.3% Incidence and mortality rates (per 100,000 persons per year) crude rate 62.6 29.6 World age-standardised rate 44.6 18.8 European age-standardised rate 71.3 32.9 cumulative ...

The Prostate Cancer Charity produces a range of leaflets and factsheets about prostate cancer , which we will send free of charge to individuals in the UK. We also provide a Confidential Helpline 0845 300 8383 staffed by experienced nurses. It is open from 10am to 4pm Monday to Friday. The nurses will answer questions from anyone concerned about prostate cancer . Calls may be monitored for training and quality purposes. We also welcome letters and email enquiries. Write to the Information and Support Service at The Prostate Cancer Charity. Prostate Cancer - The Works May 2001 The Prostate Cancer Charity, 3 Angel Walk London W6 9HX Tel: el: 020 8222 7622 Fax: ax: 020 8222 7639 Confidential Helpline: 0845 300 8383 Email: Email: info@ prostate - cancer .org.uk Orders/requests for information, ...

Prostate Cancer Profile : For the State of Nevada PDF NAVIGATION INSTRUCTIONS Click on BOOKMARKS to see a list of the pages contained in this file. Use the navigation buttons at the top or bottom of your screen to navigate through the site. Use the navigation back button at the top or bottom of your screen to go back to the first page in the file. Use the navigation end button at the top or bottom of your screen to go to the last page in this file. Use the navigation last and forward buttons at the top or bottom of your screen to go to the last page or the next page in this file. Use the magnifying glass at the top of your screen to zoom in on a page. DoIT Web Development Team LMDeSantis, March 2004 Page 2 Prostate Cancer ...

prostate cancer January 2004 Summary of submissions in response to National Health Committee consultation paper on prostate cancer screening in New Zealand Introduction This summary summarises the results of the National Health Committee?s (NHC) consultation with organisations and individuals, including consumer groups interested in prostate cancer screening. The consultation process was based on a consultation paper on prostate cancer in New Zealand distributed in September 2003. The consultation document invited submissions from the various stakeholders in the health and disability sectors. The structure of this summary follows the headings in the consultation paper. A total of 25 written submissions were received. General comments on the consultation document Some respondents expressed negative views about the consultation document suggesting that: it ...

UAMS UPDATE September 1999 University of Arkansas for Medical Sciences (501) 686-6271 . . . UAMS Medical Center To Offer Free Prostate Cancer Screenings Greene I n the past, if someone mentioned being screened for prostate cancer , Frank Milat’s response was the same as a lot of men: “What I don’t know can’t hurt me.” After undergoing a free screening at UAMS Medical Center last September, Milat knows differently. From the results of his screening, he became one of more than 209,000 American men who were diagnosed with prostate cancer in 1998. Under the care of UAMS Medical Center urologist Graham Greene, M.D., Milat has received successful treatment over the past several months. However, he never forgets the importance of that initial screening. In a continuing effort to increase prostate cancer awareness, ...

Swedish Cancer Institute Annual Oncology Symposium Prostate Cancer Friday, April 23, 2004 Glaser Auditorium Swedish Medical Center Seattle, Wash. Swedish H ealth S ervices 747 Broadway Seattle, W A 9 812 2-4 307 Non P rofit Org. U.S. P ostage PAI D Seattle, W A Permit N o. 1 564 Course Description/Statement of Need Prostate cancer is the most commonly diagnosed malignancy among men and second most common cause of cancer death in the U.S. Despite advances in our understanding of preven- tion, diagnosis, basic science and multiple treatments for prostate cancer , there are many remaining questions and several points of ongoing controversy. This course is designed to provide participants with a broad understanding of current management ...

Table of Contents Prostate Cancer Insight DMHC1853 © Datamonitor (Published 10/2003) Page 24 This report is a licensed product and is not to be photocopied TABLE OF CONTENTS ABOUT DATAMONITOR HEALTHCARE 2 About the oncology pharmaceutical analysis team 2 Casodex 150mg withdrawn for the treatment of localized disease 3 CHAPTER 1 EXECUTIVE SUMMARY 4 Prostate Cancer Insight: methodology 5 Prostate Cancer Insight: key conclusions 6 The widespread introduction of PSA screening in Europe will occur over the next 10 years, leading to a US-style stage migration. Companies with marketed or developmental prostate cancer products must target the larger localized and recurrent disease populations that will result 7 Traditionally, total androgen blockade (TAB) has been ...

ABSTRACT Surviving Prostate Cancer and Treatment: Impact on Couples Michael E. Galbraith, PhD, RN, Loma Linda University Purpose: The purpose of this study was to a) compare health status, health-related quality of life, and treatment symptoms among extended survivors of prostate cancer who have received different doses of proton-beam radiation treatment and, b) describe the relationship of health status, health-related quality of life, and marital satisfaction between extended survivors of prostate cancer and their partners. Rationale/Significance of Study: Prostate cancer is the most common diagnosed cancer in men and has immediate and long-term effects. It is estimated there will be 221,900 new cases and 28,900 deaths this year. Men=s partners are also impacted by the diagnosis and treatment of prostate cancer . Conceptual Framework: The framework ...

P r o s t a t e Cancer Prostate cancer affects mainly older men Your Health Matters < 13 Prostate cancer affects mainly older men. It is rare below the age of 50. By the age of 80, about two-thirds of men will have some cancer cells in their prostate , but in only a few will it cause problems. Most men with prostate cancer will die from some other cause rather than prostate cancer . There is no reliable screening test for prostate cancer . The PSA ( Prostate Specific Antigen) test is B r e a s t Screening Breast Cancer is the most common form of cancer among women 12 > Your Health Matters One woman in twelve will develop breast cancer by the age of 75. Each year there are 850 new cases of breast cancer and just under 300 deaths. Breast cancer ...

prostate cancer Project: Kristin Austlid Taskén, Oslo Urological University Clinic, AUH-HF (tlf. 22894269) PROSTATE CANCER Development of androgen ?independent prostate cancer ? molecular mechanisms. Prostate cancer is the most common type of cancer in Norway, with more than 2,400 new cases each year (Kreftregisteret 2002-02-13), and prostate cancer mortality in Norway is among the highest in the world - only passed by Switzerland. Androgen deprivation is the only effective systemic therapy available for metastatic prostate cancer . However, more than 50% of the cancers treated with androgen ablation therapy (surgical or medical castration) will progress to a hormone-independent state that is resistant to standard endocrine treatment. Early identification of hormone-independent cancers and new therapeutic approaches are the two main challenges for the urologist and pre-clinical researchers ...

Incidence and Mortality Rate Trends Prostate cancer is the most common cancer , excluding skin cancer , and the second leading cause of cancer -related death in men in the United States. Over time, African American men have had higher incidence and at least double the mortality rates compared to men of other racial and ethnic groups. Prostate cancer incidence rates rose dramatically in the late 1980s. This increase reflects improvements in detection and diagnosis through widespread use of PSA ( prostate -specific antigen) testing, which received initial Food and Drug Administration approval in 1986. In the early 1990s, prostate cancer incidence began declining and then leveled off in recent years. Mortality rates for prostate cancer have declined since the early 1990s. It is estimated that approximately $5.3 billion* is spent on prostate ...

Go to subscriber site A Reuters Company Monday, March 15, 2004 Clinical Genetic profile points to prostate cancer outcome Last Updated: 2004-03-15 17:00:18 -0400 (Reuters Health) By David Douglas NEW YORK (Reuters Health) - Gene expression profiling appears to offer an effective method for predicting clinical outcome in patients with prostate cancer , and could lead to tailored treatment, researchers report in the March 15th issue of the Journal of Clinical Investigation. As lead investigator Dr. Gennadi V. Glinsky told Reuters Health, "this work holds a significant promise of major improvement in clinical decision making process regarding individualized management of prostate cancer patients by allowing the physicians to make better treatment selection decisions at the time of diagnosis." Page 2 A Reuters Company ...

PROSTATE CANCER SUPPORT Onkaparinga Group South Australia We are here F O R Y O U An affiliate Member of the Prostate Cancer Foundation of Australia Mail us at: PO Box 627 Noarlunga Centre S.A. 5168 Telephone: (08) 8325-8100 and Your Family MARCH 2004 NEWSLETTER MEETING HELD AT NOARLUNGA COMMUNITY HOSPITAL ON WEDNESDAY MARCH 3 RD, 2004 FROM 6.30PM TO 8.30PM Thank you to Noarlunga Community Hospital for allowing us to use the room. Thanks also to our Sponsors Woodcroft Community Health Services and Port Noarlunga /Christies Beach R&SL Sub Branch, and to all who are supporting us. Chair: John Shields Present: 17 Apologies: Norman, Barry, Brian and Rhonda, Ann, and Laurie. And a big welcome to: Ken, Frank, Sydney, Jim and Walter. ...

Charting Your Course: Formative Evaluation of a Prostate Cancer Treatment Decision Aid Susan G. Brink, Dr.P.H. 1 , Amelia J. Birney, M.P.H. 1 , and Ann E. McFarren, R.N. 1 1 HealthMark Multimedia, LLC; Washington, DC Corresponding author: Susan G. Brink, DrPH; Principal, HealthMark Multimedia, LLC; 1870 Wyoming Ave, NW Washington, DC 20009; phone: 202.265.0033; fax: 202.328.3210; email: SGBRINK@HEALTHMARKMULTIMEDIA.COM Abstract Men with prostate cancer are faced with making a treatment decision. Charting Your Course is an interactive CD-ROM that educates patients and facilitates treatment decision-making. This paper reports formative evaluation results leading to a prototype. Prototype test results indicate an increase in knowledge about brachytherapy and staging, and in perceived ...

Let's Make Cancer History 1 8 8 8 9 3 9 - 3 3 3 3 I w w w. c a n c e r. c a Prostate Cancer What you need to know Page 2 PROSTATE CANCER What you need to know Even though we hear about cancer almost every day, when you are diagnosed with cancer you may feel alone and afraid. You may also feel overwhelmed by all the information you are given and by the need to make so many decisions. This publication will give you and your family introductory information you need when you first learn that you have prostate cancer . It will help you gain a sense of control and help you work with your healthcare team to choose the best treatments for you. Page 3 1 What is cancer ? Cancer is a disease that starts in our ...

P R O S TAT E C A N C E R Coping with a diagnosis of This booklet is provided as a free service of the Queensland Cancer Fund Page 2 1 2 Introduction 3 Understanding reactions to a prostate cancer diagnosis 7 Making decisions about prostate cancer treatments 15 Your relationship with your doctor 17 The cancer journey 19 Is there a best way to cope with having prostate cancer ? 24 Helpful thinking 29 What about my partner? 32 Feeling like a man 36 Feeling tense? Ways to reduce body tension 41 Facing the future 43 Helpful information 44 Queensland Cancer Fund contacts C O N T E N T S Page 3 2 For many men and their ...

BREAST CANCER A. What is breast cancer ? Breast cells grow out of control Cells clump together to form a mass Most breast masses are not cancerous (benign) • These do not spread outside the breast tissue • Are not life-threatening Sometimes these masses (or grouping of cells) are malignant (cancerous.) B. What are the risks factors? Sex – breast cancer is 100 times more common in females Age (75% occurs in women over 50) Race (Caucasian women are more likely than Hispanic or Black women to develop breast cancer .) Alcohol consumption. Alcohol increases estrogen levels. 1/2 – 1 drinks a day increases risk by 20%; 3 drinks day increases risk by 100%. Diet • Women who eat red meat have twice the risk as women who eat the same quantity of fish or poultry • Diets in high unsaturated fat (Fat cells produce more estrogen. Also high fat is ...